Trade Summary

4 days ago, te Boekhorst Paul Francis Olivier, serving as President and CEO at IMMUCELL CORP /DE/ (ICCC), purchased 8,000 shares at $9.50 per share, for a total transaction value of $75,960.00. Following this transaction, te Boekhorst Paul Francis Olivier now holds 17,785 shares of ICCC.

This purchase represents a 81.76% increase in te Boekhorst Paul Francis Olivier's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 18, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 22, 2026 at 8:33 AM ET, 4 days after the trade was made.

IMMUCELL CORP /DE/ operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.